⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATRA News
Atara Biotherapeutics, Inc
ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ATRA
ROSEN, A LONGSTANDING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA
accessnewswire.com
ATRA
Pomerantz LLP Announces Securities Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
Deadline Approaching: Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
businesswire.com
ATRA
ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026
globenewswire.com
ATRA
Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 22, 2026 to Discuss Your Rights - ATRA
prnewswire.com
ATRA
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
globenewswire.com
ARDX
ATRA
AMGN
Pomerantz LLP Announces Commencement of Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ATRA
Did You Lose Money Investing in Atara Biotherapeutics, Inc.? Robbins LLP Encourages Investors with Significant Losses to Contact the Firm About Their Rights Against ATRA
globenewswire.com
ATRA